{"title":"Simple and Efficient Automated Radiosynthesis of 1-[18F]-IPA Using Solid-Phase Extraction Cartridges Purification","authors":"Weixuan Dong, Cong Shen, Ruxi Chang, Zhewei Zhang, Chen Niu, Xiaoyi Duan","doi":"10.1002/jlcr.70040","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>1-[<sup>18</sup>F]Fluoroethyl-indole propionic acid (1-[<sup>18</sup>F]-IPA), a fluorinated analogue of indole-3-propionic acid (IPA), shows considerable promise as a PET tracer for imaging BxPC-3 pancreatic cancer xenografts. In the present study, we report a straightforward automated synthesis protocol that employs cartridge-based purification, providing 1-[<sup>18</sup>F]-IPA in a form suitable for human use. This method was developed in compliance with good manufacturing practice (GMP) guidelines, and the final product meets the established release specifications for radiopharmaceuticals. The automated synthesis was carried out via a two-step, one-pot procedure, which involved [<sup>18</sup>F]fluorination of methyl 1-(2-tosyloxyethyl)-1H-indole-3-propionate, subsequent hydrolysis with sodium hydroxide, and purification using a series of commercially available solid-phase extraction cartridges, thereby eliminating the need for preparative high-performance liquid chromatography (preparative HPLC). Using this one-pot approach on a modified commercial GE TRACERlab FX-FN radiosynthesis module, the final product was obtained with high uncorrected radiochemical yields (> 35 %) and radiochemical purity (> 95 %). Collectively, these results establish the GE TRACERlab FX-FN radiosynthesis module as a robust, flexible, and cost-effective platform for the routine clinical production of 1-[<sup>18</sup>F]-IPA.</p>\n </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"69 10-11","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.70040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
1-[18F]Fluoroethyl-indole propionic acid (1-[18F]-IPA), a fluorinated analogue of indole-3-propionic acid (IPA), shows considerable promise as a PET tracer for imaging BxPC-3 pancreatic cancer xenografts. In the present study, we report a straightforward automated synthesis protocol that employs cartridge-based purification, providing 1-[18F]-IPA in a form suitable for human use. This method was developed in compliance with good manufacturing practice (GMP) guidelines, and the final product meets the established release specifications for radiopharmaceuticals. The automated synthesis was carried out via a two-step, one-pot procedure, which involved [18F]fluorination of methyl 1-(2-tosyloxyethyl)-1H-indole-3-propionate, subsequent hydrolysis with sodium hydroxide, and purification using a series of commercially available solid-phase extraction cartridges, thereby eliminating the need for preparative high-performance liquid chromatography (preparative HPLC). Using this one-pot approach on a modified commercial GE TRACERlab FX-FN radiosynthesis module, the final product was obtained with high uncorrected radiochemical yields (> 35 %) and radiochemical purity (> 95 %). Collectively, these results establish the GE TRACERlab FX-FN radiosynthesis module as a robust, flexible, and cost-effective platform for the routine clinical production of 1-[18F]-IPA.
期刊介绍:
The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo.
The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.